Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2023 | Challenges in understanding the genomic landscape of Hodgkin lymphoma

Sven Borchmann • 15 Jun 2023
ICML 2023
Hodgkin Lymphoma Lymphoma

Sven Borchmann, MD, University of Cologne, Cologne, Germany, discusses the challenges in understanding the genomic landscape of Hodgkin lymphoma (HL), particularly compared to solid tumors. Dr Borchmann highlights the benefits of using circulating tumor DNA (ctDNA) to study HL genomics. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Sven Borchmann

1:17
The importance of risk-adapted therapies in Hodgkin lymphoma
Sven Borchmann • 15 Jun 2023
0:53
The current state of MRD in Hodgkin lymphoma
Sven Borchmann • 15 Jun 2023
1:47
Using peripheral blood ctDNA-sequencing for PCNSL risk profiling
Sven Borchmann • 10 Dec 2022
1:26
Improving tools and techniques for MRD detection in Hodgkin lymphoma
Sven Borchmann • 20 Oct 2022

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals